We aimed to characterize the clinical profile, EEG features and response to treatment of juvenile myoclonic epilepsy (JME) patients. We studied 103 JME probands with a standard protocol recording age of onset, type, frequency of seizures, EEG data, detailed family history and response to treatment in a superspeciality university hospital in New Delhi. The mean age of onset of disease was 14.01±3.14 years with a male to female ratio of 1.19 : 1. The myoclonic jerks were present in all the probands, generalized tonic-clonic seizures (GTCS) were present in 75.72% and 11.65% probands had absence seizures. The incidence of febrile convulsion (FC) was higher (9.7%) in our JME probands reflecting some ethnic variation or ascertainment bias. There was a considerable delay (of approximately 5.26±4.61 years) in the diagnosis of JME in our probands because most of the patients were referred from private physicians who were possibly not familiar with this epileptic syndrome in this part of the world or thought it was a milder variety of GTCS. The family history was positive in 25.24% JME probands among first-and second-degree relatives. An interictal EEG was found to be abnormal in 81 (78.64%) patients with the predominant abnormality being generalized polyspike and wave (PSW) discharges (39.80% probands). The majority of patients (80.58%) showed a good response to treatment with valproate alone. There was a subset of patients (11.65%) who required the addition of other antiepileptic drugs (AEDs) for control of GTCS: 7.76% of JME patients were diagnosed as cases of GTCS by private practitioners before they were registered in our study and their seizures were well controlled on other AEDs (without valproate) prescribed by the referring physicians (carbamazepine-4, phenytoin-2, clobazam-2).
INTRODUCTION
Juvenile myoclonic epilepsy (JME) is a common, well-defined, age related epileptic syndrome with a prevalence of 4-11% of all epilepsies 1 and incidence of 0.4-0.9% 2, 3 . JME has been classified as an idiopathic generalized epilepsy (IGE) in the classification proposed by the International League Against Epilepsy (ILAE) 4 . The syndrome is characterized by myoclonic seizures (MS) (with an average age of onset between 12 and 18 years 5 ), associated with generalized tonic-clonic seizures (GTCS) in 80-97% (with average age of onset at 16-18 years 6 ) and absence seizures (AS) in 12-54% 1, 7-11 of patients. The MS occur mainly on awakening and may be precipitated by sleep deprivation: some patients show photosensitivity. The EEG is abnormal in the majority of patients with JME. The typical features comprise generalized spike-waves (SW) (4-6 Hz) and polyspike-waves complexes 4, 5, 9, [13] [14] [15] [16] . Besides the similarity in clinical and EEG features of this syndrome across populations, the reported EEG abnormalities, seen occasionally in unaffected family members, have made this syndrome a popular model for investigating the role of hereditary factors in the pathogenesis of this syndrome 9, [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] . Linkage analysis has reported a locus near the HLA region of chromosome 6 in two population groups 27-29 but it was not confirmed by other authors 30 . However, a recent report has reconfirmed the locus at chromosome 6 31 . It is evident from these reports that hereditary factors are important in the pathogenesis of JME, however the exact pattern of inheritance has not been clarified.
The aim of this study was to define the clinical spectrum and EEG characteristics of JME in a NorthIndian population. We studied 103 patients with JME and their family members in detail to document the different aspects of the expression of this disease in North India. Data on the frequency, type of epilepsy and seizures among relatives of JME patients with a positive family history of seizures is also presented.
MATERIALS AND METHODS
All probands with the diagnosis of JME were taken from the outpatient Neurology clinic of G.B. Pant Hospital, a superspeciality university hospital in New Delhi. The inclusion criteria were:
1. Clinical evidence of bilateral myoclonic jerks with or without GTCS and/or absence seizures.
2. No evidence of neurological or intellectual deterioration.
3. An abnormal EEG with bilateral symmetrical generalized spikes or polyspike and slow-wave discharges (a normal EEG was acceptable if the above-mentioned clinical criteria were strictly met).
Normal CT/MRI scan (if performed).
Exclusion criteria:
1. Patients with evidence of neurological or intellectual deterioration.
2. Abnormal CT/MRI brain.
3. Myoclonic jerks secondary to brain hypoxia, metabolic or degenerative disease.
The patients who satisfied all the above criteria were studied prospectively with a standard uniform protocol. The type and frequency of seizures, precipitating factors, EEG data, detailed family history and response to treatment were studied in all the patients. All the family members were studied in detail and a family pedigree was constructed including first-and second-degree relatives. The seizure types/epileptic syndromes were classified according to the classification proposed by ILAE 1989 32 .
At least one conventional scalp EEG was recorded in all the patients with conventional provocative procedures (hyperventilation, intermittent photic stimulation). In a few the patient's natural sleep EEG was recorded (without any modification of antiepileptic treatment). The EEG was considered abnormal when definite bilaterally symmetrical generalized SW or polyspike and slow-wave discharges were seen. CT/MRI of the brain was done when indicated to rule out other causes of MS such as hypoxia, degenerative diseases, metabolic diseases. In those patients with a normal EEG, a repeat EEG (sleep deprived) was done to document any abnormal discharge.
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RESULTS
There were 47 females and 56 males among 103 JME probands with a male female ratio of 1.19 : 1. The mean age of patients at the time of presentation was 21.91 ± 7.12 years while the mean age of the onset of the disease was 14.01 ± 3.14 years. The duration of illness was 5.52 + 5.10 years. All the patients had myoclonic jerks (100%), while GTCS were present in 78 patients (75.72%) and 12 patients (11.65%) had absence seizures. Most of the patients were diagnosed late. The delay in the diagnosis was 5.26 ± 4.61 years. The myoclonic jerks were the presenting symptom in 39 (37.86%) followed by GTCS in 14 (13.59%), myoclonic jerks occurring around the same time as GTCS in 50 (48.54%) patients. Myoclonic jerks with GTCS was the commonest combination present in 74/103 (71.84%) of JME probands (Fig. 1) . The mean age of presentation with myoclonic jerks was 14.46 ± 3.21 years and with GTCS was 15.95 ± 4.92 years (Table 1) . Myoclonic jerks on premature awakening were recorded in 76 (73.78%) probands and after sleep deprivation in 60 (58.25%) probands (Table 1 ). The myoclonic jerks were localized to (Table 2) . Of these 10 patients GTCS were present in six and complex partial seizures (CPS) in four probands during the febrile convulsions ( Table 2 ). All these patients went on to develop myoclonic jerks and GTCS while three experienced absence seizures later on in life. 
Antiepileptic drug treatment
The 103 patients with JME undergoing investigation are in regular follow up with ourselves. Out of these, 83 patients (80.58%) have been seizure free on valproate alone for the last 15 years. Twelve patients (11.65%) continued to have GTCS with a frequency ranging from one to three per month, while myoclonic jerks were well controlled. Therefore other antiepileptic drugs (AEDs) were added (clonazepam, phenobarbitone, clobazam and phenytoin) to control GTCS (Table 3) , but four patients (3.88% of all JME cases) still continue to have GTCS at a frequency of one seizure in 36 months. The remaining eight (7.76%) patients with JME were misdiagnosed as cases of primary GTCS by private physicians before registry in our study. They had never been treated with valproate, but had good seizure control with other AEDs (carbamazepine-4, clobazam-2, phenytoin-2) before coming to the authors: therefore, they were continued on the same medications. 
Family history
A family history of seizures was positive in 26 (25.24%) probands among first-and seconddegree relatives. Sixteen probands had only firstdegree relatives with seizures; eight had only seconddegree affected relatives, while two had both firstand second-degree relatives with seizures. JME was noted in five first-degree relatives and two seconddegree relatives of JME probands. Idiopathic and symptomatic generalized epilepsies were present in 10 and five first-degree relatives, respectively and four and five second-degree relatives, respectively. Febrile seizures were present in two of the first-and two of the second-degree relatives.
DISCUSSION
The clinical and EEG characteristics of 103 probands with JME studied in a tertiary care super speciality centre are similar to those from other centres in the world 3, 8, 9, 13, 14 in some aspects. In some original large series 8, 9, 11 of JME the sex distribution was found to be approximately 1 : 1, as found in our study (1.19 : 1). We found that myoclonic jerks were the presenting complaints (37.86%) in the majority of probands as in other studies 5, 6, 9, 23 . These myoclonic jerks either preceded GTCS or occurred around the same time. Possibly this is of considerable diagnostic relevance to differentiate this epileptic syndrome from GTCS on awakening. Different types of seizures presented in combination in many JME patients during the course of their illness, out of which myoclonic jerks with GTCS was the commonest combination present in 71.84% (74) of JME probands, while myoclonic jerks alone was the presenting feature in 16.50% (17) , myoclonic jerks with GTCS and absence seizures together were present in 3.88% (four) and myoclonic with absence seizures were present in 7.76% (eight) of JME probands ( Table 1 , Fig. 1 ).
There was a considerably delay of approximately 5.26 ± 4.61 years in the diagnosis of JME in our probands because most of the patients were referred from private physicians and they were possibly not familiar with this epileptic syndrome in this part of the world or they thought that it was a milder variety of GTCS. In concordance with our finding, JMK Murthy 33 has reported a diagnostic delay of 6.3 years in patients with JME and postulated that lack of familiarity with this clinical syndrome in physicians was responsible for this delay in diagnosis and initiation of proper treatment. The mean age of the onset of myoclonic jerks and GTCS was 14.46 and 15.95 years, respectively, which is similar to reports from other parts of the world 1, 7, 9, 11, 35, 36 . Myoclonic jerks alone have been reported to occur in 7-17% of cases diagnosed as JME 11, 15 . We found myoclonic jerks alone in 16.50% (17/103) of probands of JME. GTCS were present in 75.72% (78/103) of probands ( Table 1 ) similar to that reported in the original large series 1, 8, 12, 13 . The presence of absence seizures in 11.65% of JME probands (12/103) is also concordant to that of 10-37% reported in a series of patients belonging to different ethnic groups 8, 12, 13, 37 . Jain 34 has reported absence seizures in 27 of 329 (9%) probands and Murthy reports 27 of 131 (20.6%) of JME probands. This wide range (9-20.6%) of absence seizures reveals some genetic heterogeneity in Indian probands or may be due to ascertainment bias.
In contrast to the earlier studies we found a high incidence of FC (9.7%) in JME probands (Table 2) . Janz 15 has reported a lower incidence (4.4%) of FC in JME probands while earlier reports from India (Jain et al.) 17, 35 have also reported a lower incidence (4-5%) of FC. A higher incidence of febrile seizures (4.4-10%) has been documented in JME as well 38 . It may be due to ethnic variation or ascertainment bias as isolated events early in life may be forgotten. All these patients with FC later developed GTCS and myoclonic jerks. This might reflect an increased susceptibility to develop both types of seizure in patients having FC.
In our series a positive family history (25.24%) among first-and second-degree relatives is comparable to other studies (25-65%) conducted in different ethnic groups [19] [20] [21] [22] [23] [24] [25] . Jain et al. 35 reported a positive family history in 35%, Murthy 36 reported 23.6% and Mani et al. 39 reported it in 44% of probands. The difference in family history (23.6-44%) in an Indian population is in concordance with studies from other parts of the world, indicating a genetic heterogeneity in JME probands. An abnormal EEG was present in most of the patients (78.64%) and PSW was the commonest finding (39.80%), comparable to other studies 1, 9, 12, 35 (Fig. 2) . Most of these abnormal EEGs were done in unmedicated probands. In 4.87% of probands a repeat EEG showed abnormal PSW activity reflecting the importance of recording the EEG several times. A PPR in the EEG was noted in 11.65% of JME probands. Studies from South India showed PPR in 13-22% of JME probands 37 . Pedersen et al. 7 observed a PPR in seven out of 43 cases.
The majority of probands (80.58%) responded to valproate treatment alone, while a few required the addition of another AED. There was a subset of patients (11.65%) whose GTCS were not controlled on valproate alone, but controlled on clobazam, phenobarbitone, clonazepam and phenytoin. This probably reflects a distinct subset of JME probands, resistant to valproate. Unresponsiveness to valproate has also been discussed in earlier studies 35, 39 . Valproate resistant JME requires a further detailed comparative study of a larger number of patients.
